Valeant Pharmaceuticals has entered into an agreement to acquire B+L for $8.7 billion, which includes $4.2 billion in debt. The deal is expected to close in Q3, and B+L will retain its name.

B+L subsidiary Ista pleads guilty to conspiracy charges in anti-kickback case and agrees to pay $34M in civil and criminal fines.

Study shows that patients wearing 1-Day Acuvue TruEye lenses exhibit no clinically significant differences as compared to spectacle wearers after a year of lens wear.

Study shows retinal imaging technology better detects retinal lesions compared with ophthalmoscopy.

Industry supports EyeXam mobile app to help users find local eyecare practitioners.

Senju acquired the rights to co-develop and market Allegro's integrin peptide therapy for intravitreal injection for vascular eye diseases such as AMD and diabetic macular edema.

Dr. Ernie Bowling shares how Lou Catania’s final lecture before retirement spurs a memory of a great teacher.

Two new studies add to the growing evidence that time spent outdoors helps reduce the risk of myopia in children.

Optometry Giving Sight announces its Philanthropist of the Year, Practice of the Year, and World Sight Day Challenge Outstanding Contribution.

The American Optometric Association joins the American Society of Cataract and Refractive Surgery in tackling integrated eye care and patient delivery.